Operation of heartburn provides little protection against esophageal cancer

February 23, 2010, Karolinska Institutet

(PhysOrg.com) -- Severe heartburn is the most important risk factor for suffering from glandular cell carcinoma (adenocarcinoma) in the esophagus. Scientists have therefore hoped that surgery for heartburn should have a protective effect against this aggressive cancer. However, a large Swedish study, published in the scientific journal Gastroenterology, show that patients who undergo surgery for heartburn still are in high risk of having esophageal cancer a long time after they have had surgery.

"This is obviously disappointing. But it could also be that surgery often is performed too late to prevent cancer. Persons who are selected to undergo surgery for heartburn have usually encountered serious problems for a long time before the discussion of surgery arises," says Professor Jesper Lagergren of the Karolinska Institute, who led the study.

Morbid degree of heartburn affects 10-20 percent of all adults in the western world. Heartburn arises when Cardia is not closed properly, allowing the stomach acid to penetrates into the gullet. Risk factors are heredity, obesity, smoking and certain medications. Treatment is done primarily by acid inhibitory drugs or, in selected cases, surgery.

Since heartburn is also the strongest risk factor for , researchers hoped that the operation against heartburn will prove to have a protective effect. The chance of surviving five years after diagnosis of esophageal cancer is set is only 10-15 percent, making the search for preventive measures very important. Esophageal cancer has increased rapidly in the Western world over the past decades.

In the present study, a research team at Karolinska Institutet led by Jesper Lagergren, examined the risk of esophageal cancer in 14 102 Swedes who previously had surgery for heartburn. The study, which is the most comprehensive in its field, cover all heartburn surgery in Sweden since 1965 and has a follow-up time of up to 42 years. The results show that those who had surgery for heartburn had continued high risk of esophageal cancer during the follow-up. Thus, the team believes that this operation can not be stated as a reason for the prevention of esophageal cancer for patients with severe . In its analysis, the researchers adjusted their results for the effects of age, gender and time. On the other hand, they have not been able to take into account risk factors such as and smoking.

The researchers will continue to investigate why the operation do not affect esophageal cancer by studying the operations carried out and the patients increased incidence of other risk factors for those who developed esophageal cancer.

More information: Lagergren J., Ye W., Lagergren P., Lu Y. Antireflux surgery and risk of esophageal adenocarcinoma, Gastroenterology, Epub ahead of print 18 Jan 2010, DOI:10.1053/j.gastro.2010.01.004

Related Stories

Recommended for you

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

Presurgical targeted therapy delays relapse of high-risk stage 3 melanoma

January 17, 2018
A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared to standard-of-care surgery for patients with stage 3 disease, researchers at ...

Dulling cancer therapy's double-edged sword

January 17, 2018
Researchers have discovered that killing cancer cells can actually have the unintended effect of fueling the proliferation of residual, living cancer cells, ultimately leading to aggressive tumor progression.

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

More evidence of link between severe gum disease and cancer risk

January 16, 2018
Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by epidemiologists ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.